A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension | ||
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas | |
| dc.conicet.organizacion | Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas | |
| dc.contributor.author | Sookoian, Silvia Cristina | |
| dc.contributor.author | Castaño, Gustavo Osvaldo | |
| dc.contributor.author | Garcia, Silvia Ines | |
| dc.contributor.author | Viudez, Pedro | |
| dc.contributor.author | González, Claudio | |
| dc.contributor.author | Pirola, Carlos Jose | |
| dc.date.issued | 2005-03 | |
| dc.description.abstract | OBJECTIVE: Losartan, a dose of 25 mg/day, has been found to be effective in 50% of patients with portal hypertension without adverse effects. We evaluated the relationship between genetic polymorphisms of the renin-angiotensin system (A1166C angiotensin II type 1 receptor (AT1R), angiotensinogen T174M and M235T, and angiotensin-converting enzyme I/D) and the effects of losartan on portal and systemic hemodynamic in patients with cirrhosis and portal hypertension. METHODS: We performed a longitudinal study that included 23 consecutive patients with cirrhosis and esophageal varices who received 25 mg/day of losartan during 12 wk. Hepatic venous pressure gradient (HVPG) and systemic hemodynamic were measured at baseline and after treatment. Genomic DNA was extracted from peripheral blood leukocytes; genetic polymorphisms of the renin-angiotensin system were investigated by polymerase chain reaction and restriction fragment length polymorphisms. RESULTS: The homozygous patients for AT1R A allele showed higher pulmonary-wedged and free hepatic venous pressure on baseline. After treatment, they showed a higher decrease of HVPG (32.5% ± 19.2) in comparison with patients with AC/CC genotype (2.4% ±18.9), p < 0.01. Ten of 15 patients with AA genotype were responders, while only one of eight with AC/CC genotype (p < 0.002); genotype AA showed a positive predictive value of 66.6% and negative predictive value of 87.5%. CONCLUSIONS: These results suggest that there is a relationship between the AT1R A1166C polymorphisms and the therapeutic response to losartan. The genetic testing may be used as a predictive factor of this response. | es |
| dc.description.fil | Fil: Sookoian, Silvia Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | |
| dc.description.fil | Fil: Castaño, Gustavo Osvaldo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | |
| dc.description.fil | Fil: Garcia, Silvia Ines. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | |
| dc.description.fil | Fil: Viudez, Pedro. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | |
| dc.description.fil | Fil: González, Claudio. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | |
| dc.description.fil | Fil: Pirola, Carlos Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Médicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Médicas; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Sookoian, Silvia Cristina; Castaño, Gustavo Osvaldo; Garcia, Silvia Ines; Viudez, Pedro; González, Claudio; et al.; A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension; Lippincott Williams; American Journal Of Gastroenterology; 100; 3; 3-2005; 636-642 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0002-9270 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/186378 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 3 | es |
| dc.journal.pagination | 636-642 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | American Journal Of Gastroenterology | es |
| dc.journal.volume | 100 | es |
| dc.language.iso | eng | es |
| dc.publisher | Lippincott Williams | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://journals.lww.com/ajg/Abstract/2005/03000/A1166C_Angiotensin_II_Type_1_Receptor_Gene.22.aspx | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/j.1572-0241.2005.41168.x | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | AT1R | es |
| dc.title | A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.c38748e2-9271-49c5-bb84-53a1863dcc8a_A.pdf
- Tamaño:
- 103.65 KB
- Formato:
- Adobe Portable Document Format